With 30 years of experience in diagnostics and life sciences, I have a solid track record of executing effective strategies, enhancing shareholder value, and fostering strong relationships with customers, partners, and investors.I’m currently the Chief Commercial Officer (CCO) at Quantum-Si, where I lead the charge in revolutionizing the field of protein sequencing. My role involves spearheading the global commercialization of our cutting-edge technology, which is designed to make protein sequencing more accessible and impactful for researchers and clinicians worldwide.Before joining Quantum-Si, I served as the CCO at Nuclein and CCO at Binx Health, where I advanced the commercialization of innovative POC PCR platforms. Prior to that, I led Global Commercial Operations at Luminex Corporation, where, as a corporate officer, I managed multiple global business units, oversaw complex commercial integration projects, and drove both domestic and international growth. My expertise includes licensing, joint ventures, mergers and acquisitions, portfolio planning, product development, and marketing.I’m passionate about building and leading high-performing teams, fostering a culture of excellence and collaboration, and creating value for all stakeholders.